Effects of orthotopic liver transplantation on the corrected QT interval in patients with end-stage liver disease

被引:28
|
作者
Carey, EJ
Douglas, DD
机构
[1] Mayo Clin Hosp, Div Transplantat Med, Phoenix, AZ 85054 USA
[2] Mayo Clin, Div Gastroenterol & Hepatol, Scottsdale, AZ USA
关键词
autonomic dysfunction; end-stage liver disease; QT interval;
D O I
10.1007/s10620-005-1603-3
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Autonomic dysfunction is a recognized complication of end-stage liver disease (ESLD) associated with a poor prognosis. The corrected QT interval (QTc) on electrocardiogram is a marker of autonomic function. A few small studies have suggested that QTc may normalize with the return of liver function after orthotopic liver transplantation. We sought to determine how transplantation affects the QTc in patients with ESLD. The QTc from the pretransplantation evaluation of 46 patients with ESLD was compared with the QTc at 4-month posttransplantation follow-up. Other factors that can influence autonomic function also were evaluated. Most patients with ESLD (54%) showed a prolonged QTc (greater than or equal to 440 msec) at the pretransplantation evaluation ( 451 +/- 45 msec) that improved to within the normal range at posttransplantation follow-up ( 418 +/- 18 msec; P < 0.001). There was no relationship between QTc prolongation and Child - Turcotte - Pugh score, Model for End-Stage Liver Disease score, diabetes mellitus, age, or etiology of liver disease. Most patients with ESLD and a prolonged QTc will have a significant improvement in QTc after transplantation; however, 6.5% of patients in our study had a worsening of QTc after transplantation.
引用
收藏
页码:320 / 323
页数:4
相关论文
共 50 条
  • [31] THE NATURE OF MALNUTRITION IN CHILDREN WITH END-STAGE LIVER-DISEASE AWAITING ORTHOTOPIC LIVER-TRANSPLANTATION
    CHIN, SE
    SHEPHERD, RW
    THOMAS, BJ
    CLEGHORN, GJ
    PATRICK, MK
    WILCOX, JA
    ONG, TH
    LYNCH, SV
    STRONG, R
    AMERICAN JOURNAL OF CLINICAL NUTRITION, 1992, 56 (01): : 164 - 168
  • [32] Liver Regeneration and Cell Transplantation for End-Stage Liver Disease
    Li, Yan
    Lu, Lungen
    Cai, Xiaobo
    BIOMOLECULES, 2021, 11 (12)
  • [33] Liver transplantation in the era of model for end-stage liver disease
    Wang, VS
    Saab, S
    LIVER INTERNATIONAL, 2004, 24 (01) : 1 - 8
  • [34] Sarcopenia in end-stage liver disease and after liver transplantation
    Leunis, S.
    Vandecruys, M.
    Craenenbroeck, A. H. Van
    Cornelissen, V.
    Bogaerts, S.
    De Smet, S.
    Monbaliu, D.
    ACTA GASTRO-ENTEROLOGICA BELGICA, 2023, 86 (02) : 323 - 334
  • [35] LIVER-TRANSPLANTATION FOR END-STAGE LIVER-DISEASE
    VOGTEN, AJM
    NETHERLANDS JOURNAL OF MEDICINE, 1986, 29 (08): : 233 - 234
  • [36] Renal Failure in End-stage Liver Disease and Liver Transplantation
    Planinsic, Raymond M.
    Lebowitz, Jonathan J.
    INTERNATIONAL ANESTHESIOLOGY CLINICS, 2006, 44 (03) : 35 - 49
  • [37] The case for liver transplantation in end-stage alcoholic liver disease
    Batey, RG
    DRUG AND ALCOHOL REVIEW, 1996, 15 (02) : 183 - 188
  • [38] Celiac Disease and End-Stage Liver Disease Requiring Liver Transplantation
    Tsai, Chung-Jyi
    Tsai, Grace
    GASTROENTEROLOGY, 2013, 144 (05) : S450 - S450
  • [40] Impact of simultaneous splenectomy and orthotopic liver transplantation in patients with end-stage liver diseases and splenic hyperfunction
    Li, De-Wei
    Du, Cheng-You
    Fan, Bin
    Huang, Ping
    Luo, Shi-Qiao
    He, Qiang
    HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL, 2012, 11 (05) : 489 - 493